Aeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting Officer
September 01 2017 - 4:30PM
Business Wire
Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the
“Company”) announced today the departure of the Company’s Vice
President, Finance & Chief Accounting Officer, Geneviéve
Lemaire, effective on or before September 30, 2017.
The Company is currently reviewing its resource requirements
with respect to its finance department and has commenced a search
for Ms. Lemaire's replacement as principal financial officer.
The Company thanks Ms. Lemaire for her contributions and wishes
her success in her future endeavors.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a specialty biopharmaceutical company
engaged in developing and commercializing novel pharmaceutical
therapies. We are engaged in drug development activities and in the
promotion of products for others. We recently resubmitted an NDA to
the FDA seeking approval of Macrilen™, an internally developed
compound. The focus of our business development efforts is the
acquisition of licenses to products that are relevant to our
therapeutic areas of focus. We also intend to license out certain
commercial rights of internally developed products to licensees in
non-U.S. territories where such out-licensing would enable us to
ensure development, registration and launch of our product
candidates. Our goal is to become a growth-oriented specialty
biopharmaceutical company by pursuing successful development and
commercialization of our product portfolio, achieving successful
commercial presence and growth, while consistently delivering value
to our shareholders, employees and the medical providers and
patients who will benefit from our products. For more information,
visit www.aezsinc.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170901005721/en/
Aeterna Zentaris Inc.Michael V. Ward, 843-900-3223Chief
Executive OfficerIR@aezsinc.comorBayfield Strategy,
Inc.1-844-226-3222 (North American Toll Free Number)1-416-855-0238
(Outside North America)info@bayfieldstrategy.com
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aeterna Zentaris (NASDAQ:AEZS)
Historical Stock Chart
From Sep 2023 to Sep 2024